The Involvement of Glycosaminoglycans in Airway Disease Associated with Cystic Fibrosis
Individuals with cystic fibrosis (CF) present with severe airway destruction and extensive bronchiectasis. It has been assumed that these structural airway changes have occurred secondary to infection and inflammation, but recent studies suggest that glycosaminoglycan (GAG) remodelling may be an imp...
Main Authors: | Emer P. Reeves, David A. Bergin, Michelle A. Murray, Noel G. McElvaney |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2011.81 |
Similar Items
-
Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis
by: Emer P. Reeves, et al.
Published: (2012-01-01) -
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin DA, et al.
Published: (2013-01-01) -
Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences
by: Gillian M. Lavelle, et al.
Published: (2016-01-01) -
Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
by: Karen McQuillan, et al.
Published: (2020-07-01) -
Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease
by: Michelle M. White, et al.
Published: (2017-09-01)